Virtual care infrastructure is rewriting health system procurement
Late-2026 digital health capital is moving toward the plumbing layer of care delivery, and that shift changes how CIOs, CFOs and CMOs evaluate telehealth contracts, concentration risk and switching costs.
Something quiet is happening in how health systems buy digital care. Virtual care infrastructure, not virtual care as a product, is where late-2026 capital and conference agendas are converging. The visible signal is funding flowing to pharmacy benefits technology and clinical workflow tooling rather than to consumer-facing video visit brands. The less visible signal is that procurement committees are starting to evaluate telehealth the way they evaluate an interface engine.
The money moved to the plumbing layer
Fierce Healthcare's rolling 2026 fundraising tracker, updated in early October, leads with two rounds that look nothing like the consumer telehealth story of the early 2020s. Rightway raised $155M to expand pharmacy benefits technology. Basalt Health raised $20M. Neither is selling a destination app. Both sit underneath transactions that already happen inside a health plan or a clinical workflow.
That is a meaningful shift in what investors believe is defensible. A direct-to-consumer virtual care brand has to win attention every quarter. An enablement layer that routes a prescription, a prior authorization or a documentation event earns revenue whether or not the patient knows the vendor's name. For provider organizations, the practical consequence is that the vendors with the most runway are increasingly the ones embedded deepest in operations and hardest to remove.
When the vendor sits at the edge of the workflow, a wind-down is an inconvenience. When it sits underneath scheduling or pharmacy, it is an operational incident.
When a conference renames the category, buyers have already moved
Becker's has built a named session around "Telehealth as Infrastructure: What's Next" inside its 11th Annual IT + Revenue Cycle Conference, positioning the topic alongside the future of AI and digital health. Conference programming is a lagging indicator of vendor marketing but a leading indicator of buyer language. Agenda titles get written because organizers heard the phrasing in enough CIO conversations to believe it will fill a room.
The American Hospital Association's Center for Health Innovation has framed its 2026 Market Scan coverage similarly, profiling digital health projects as care-delivery transformation rather than as pilots. That is provider-side institutional framing. Pilot language implies a contained budget, a sunset date and a steering committee. Infrastructure language implies a line item that renews, a dependency map and an owner inside IT operations.
272 vendors, narrowing capital
Becker's 2026 list of telehealth companies to know runs to 272 names. Set that against a funding environment concentrating into fewer, larger enablement rounds and the tension becomes clear. The supply side of the market is still highly fragmented while the capital side is consolidating around a smaller set of winners. Most of those 272 companies are not going to raise a $155M round.
For a health system, vendor count is not a measure of choice so much as a measure of future churn. Every contract signed with a thinly capitalized point solution in 2026 carries an implicit question about who owns that code in 2028. When the vendor sits at the edge of the workflow, a wind-down is an inconvenience. When it sits underneath scheduling or pharmacy, a wind-down is an operational incident.
Procurement logic inverts for CIOs, CFOs and CMOs
If virtual care is infrastructure, the evaluation criteria change. The question stops being whether clinicians like the video experience and starts being what breaks if the platform degrades. Three risks move to the front of the review. Integration debt accumulates when a funded vendor pivots its roadmap toward the segment that attracted the capital, leaving provider-specific features unmaintained. Concentration risk builds when a single platform quietly sits under scheduling, documentation and revenue cycle at the same time. Contract durability becomes a real diligence item in a market with hundreds of suppliers and tightening capital.
The accountability split is uneven. CMOs inherit the clinical continuity risk, because a failed virtual care dependency shows up as cancelled visits and broken follow-up, particularly in service lines that lean heavily on remote delivery. CFOs inherit the switching cost, which is rarely the license fee and almost always the migration, retraining and revenue cycle cleanup. CIOs sit between them, holding a dependency map that most organizations have never formally drawn.
Behavioral health deserves separate scrutiny. That segment continues to face a reimbursement cliff dynamic distinct from general Medicare virtual care, and leaders should confirm the current policy status with their own government affairs teams before locking multi-year commitments. The same applies to CMS virtual care billing posture heading into FY2027, which remains an open variable in any multi-year business case.
What to change in the next contract cycle
Practical steps are available now. Build a dependency map that shows every workflow touching each virtual care vendor, then flag any supplier appearing in more than two. Add financial viability review to digital health diligence with the same seriousness applied to core clinical systems, including funding stage, burn signals and customer concentration. Negotiate data portability and source code escrow terms before signing, not during a crisis.
Finally, assign a named executive owner for virtual care infrastructure the way systems assign one for the network or the EHR. Fragmented ownership is what allowed telehealth to be purchased as a bolt-on in the first place. As it becomes a dependency, unowned infrastructure is the most expensive kind.
